Top Markets
Coin of the day
SpectraScience, Inc. SpectraScience, Inc.

SpectraScience, Inc.

SCIE
Rank in Stocks #42097
SpectraScience, Inc. specializes in creating and distributing an advanced... SpectraScience, Inc. specializes in creating and distributing an advanced technological platform designed for the immediate classification of tissue as normal, pre-cancerous, or cancerous, thereby bypassing the requirement for invasive physical biopsies. This innovative approach is accessible in the United States, Europe, and other global regions. The company's product line includes the WavSTAT3 optical biopsy system, which assesses colon tissue for normal, pre-cancerous, or cancerous conditions without surgical removal. Another key offering is the WavSTAT4 optical biopsy system, a diagnostic tool for the colon that employs UV laser light to optically scan and analyze tissue, enabling physicians to make instant diagnoses during endoscopic cancer screenings. Additionally, SpectraScience provides related accessories such as mobile consoles and disposable forceps. The company is also actively developing an application for esophageal diagnostics, focused on identifying pre-cancerous and cancerous tissue formations. Founded in 1983, the company operated as GV Medical, Inc. until it adopted the name SpectraScience, Inc. in October 1992, and is headquartered in San Diego, California.
Share Price
$0.000001
Last synced: 2025-08-26
Market Cap
$4.92K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade SpectraScience, Inc. (SCIE)

Category

Number of shares outstanding for SpectraScience, Inc. (SCIE)
Number of shares outstanding as of August 2026: 0
According to SpectraScience, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for SpectraScience, Inc. (SCIE) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors